Is Spike Antibody Neutralizing?

SARS-Cov2-Neutralizing-Antibody(Spike)

E28F03095-100ug N/A
EUR 444.44
Description: N/A

Human IgG antibody Laboratories manufactures the is spike antibody neutralizing? reagents distributed by Genprice. The Is Spike Antibody Neutralizing? reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Antibody. Other Is products are available in stock. Specificity: Is Category: Spike Group: Antibody Neutralizing?

Anti-2019-nCoV Spike Neutralizing Antibody

50uL
EUR 390
Description: Unconjugated

Anti-2019-nCoV Spike Neutralizing Antibody

each Ask for price
Description: Unconjugated

Anti-2019-nCoV Spike Neutralizing Antibody

100uL
EUR 650
Description: Unconjugated

Anti-2019-nCoV Spike Neutralizing Antibody

50uL
EUR 390
Description: Unconjugated

Anti-2019-nCoV Spike Neutralizing Antibody

each Ask for price
Description: Unconjugated

Spike Neutralizing Antibody (Clone G10xA1) (SARS-CoV-2)

100 µg
EUR 600
Description: This monoclonal antibody recognizes the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2 [Table of Variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the Spike S1 RBD (B.1.1.529, Omicron Variant) (SARS-CoV-2):ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience #78339).

Spike Neutralizing Antibody (Clone G10xA5) (SARS-CoV-2)

100 µg
EUR 600
Description: This monoclonal antibody recognizes the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2 [Table of Variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the Spike S1 RBD (B.1.1.529, Omicron Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience, #78339).

Antibody Neutralizing? information

Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AS35)

SAD-S35 100ug
EUR 2974.6
Description: Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AS35) (SAD-S35) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2 with an IC50 of 1.47 μg/mL using SARS-CoV-2 Inhibitor Screening Kit.Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARS-CoV-2 Spike protein.

SARS-CoV-2 Spike RBD (Bebtelovimab biosimilar) Neutralizing Antibody

E-AB-V1029-100uL 100uL
EUR 480
Description: Unconjugated

SARS-CoV-2 Spike RBD (Bebtelovimab biosimilar) Neutralizing Antibody

E-AB-V1029-200uL 200uL
EUR 860
Description: Unconjugated

SARS-CoV-2 Spike RBD (Bebtelovimab biosimilar) Neutralizing Antibody

E-AB-V1029-each each Ask for price
Description: Unconjugated

Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Mouse IgG1 (AM122)

SCT-M369 100ug
EUR 2974.6
Description: Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Mouse IgG1 (AM122) (SCT-M369), originally from mouse immunized with recombinant SARS-CoV-2 Spike RBD protein, is recombinantly expressed from HEK293 cells.

OAAQ00225-20UL - SARS-CoV-2 Spike S1 (C-A11) Neutralizing Antibody

OAAQ00225-20UL 20uL
EUR 200

OAAQ00225-200UL - SARS-CoV-2 Spike S1 (C-A11) Neutralizing Antibody

OAAQ00225-200UL 200uL
EUR 540

Spike S1 Neutralizing Antibody (VHH), Fc-fusion (IgG1), Avi-Tag (SARS-CoV)

100784 100 µg
EUR 595
Description: SARS-CoV monoclonal Spike S1 VHH neutralizing antibody, a.a. 1-127(full length), with C-terminal Avi-Tag™ fused to the Fc portion of Human IgG1, expressed in a HEK293 cell expression system. MW = 43 kDa. VHHs are single-domain antibodies from camelids.

SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) Neutralizing Antibody

abx376487-1096tests 10 × 96 tests Ask for price

SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) Neutralizing Antibody

abx376487-596tests 5 × 96 tests
EUR 343.75

SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) Neutralizing Antibody

abx376487-96tests 96 tests
EUR 243.75

SARS-CoV-2 Spike Protein RBD (Omicron B.1.1.529 Variant) Neutralizing Antibody

abx376490-96tests 96 tests
EUR 343.75

Mouse Anti-SARS-CoV-2 Spike Neutralizing Monoclonal antibody, clone NN54

CABT-CS064 100 µg
EUR 889.35
Description: Mouse

Mouse Anti-SARS-CoV-2 Spike Neutralizing Monoclonal antibody, clone NN68

CABT-CS065 100 µg
EUR 997.5
Description: Mouse

Anti-SARS-CoV-2 Neutralizing Antibody Titer Serologic Assay Kit (Spike RBD)

RAS-N022 96tests
EUR 631.3
Description: It's been reported that coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Anti-SARS-CoV-2 Neutralizing Antibody Quantitative Detection Kit (Spike RBD)

RAS-N044 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses continual threat to human health due to rapid transmission worldwide.Anti-SARS-CoV-2 Neutralizing Antibody Quantitative Detection Kit (Spike RBD)to test the protective neutralizing antibody levels in post-vaccination serum or convalescent serum.

Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM122)

S1N-M122 100ug
EUR 2974.6
Description: Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM122) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 protein. As verified in competitive ELISA-based and pseudovirus-based neutralization assay, this chimeric monoclonal can potently neutralize all SARS-CoV-2 Variants of Concern (VOCs), including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.1.529).